Spark Therapeutics enters into definitive merger agreement with Roche

4BIO portfolio company Orchard Therapeutics announces ADA-SCID follow-on results

4BIO portfolio company Orchard Therapeutics goes public

4BIO portfolio company Orchard Therapeutics Announces $150 Million Series C Financing

GSK Hands Off Rare Disease Gene Therapy Portfolio to Orchard Therapeutics

TiGenix and Takeda announce Alofisel® (darvadstrocel) receives approval